Overview
What is International Society For Cns Drug Development?
The International Society for CNS Drug Development is a nonprofit organization with a primary focus on advancing the field of central nervous system (CNS) drug development. Their key activities involve the development and refinement of assessment scales, such as the GRID HAM-D rating scale and continued work on the DID rating scale. Furthermore, they sponsor and organize scientific meetings and conduct methodological research in CNS clinical trials to drive innovation and progress in this field.
Official website here: www.iscdd.org
Is International Society For Cns Drug Development legitimate?
International Society For Cns Drug Development is a legitimate nonprofit organization registered as a 501(c)(3) entity. International Society For Cns Drug Development submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $127,000
Professional Fundraising Fees: $0
Other Salaries and Wages: $34,398
For more financial information, click here
Official website here: www.iscdd.org
What is the mission statement of International Society For Cns Drug Development?
The International Society for CNS Drug Development is committed to promoting advancements in the field of central nervous system (CNS) clinical trials. This is achieved through the development and continuation of the GRID HAM-D and DID rating scales. Additionally, the organization sponsors and conducts methodological research in CNS clinical trials. Furthermore, they organize and support scientific meetings to facilitate knowledge sharing and collaboration within the industry.
Official website here: www.iscdd.org
What is the revenue of International Society For Cns Drug Development?
International Society For Cns Drug Development's revenue in 2024 was $332,093.
Official website here: www.iscdd.org
Who are the executives of International Society For Cns Drug Development and what are their salaries?
The average compensation at International Society For Cns Drug Development during 2024 was $53,799. There are 3 employees at International Society For Cns Drug Development.
Here are 3 key members and their salaries:
- Compensation: $127,000
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.iscdd.org
Where can I find the form 990 for International Society For Cns Drug Development?
International Society For Cns Drug Development's most recent form 990 was submitted in 2024 and can be accessed here.
Official website here: www.iscdd.org
Learn more at the official website: www.iscdd.org
Mission Statement of International Society For Cns Drug Development
The International Society for CNS Drug Development is committed to advancing its mission by sponsoring and conducting scientific meetings, as well as engaging in research. A significant part of its mission involves the development and continuous improvement of the GRID HAM-D rating scale and the DID rating scale. These scales are instrumental in assessing the severity of symptoms in patients with central nervous system disorders, contributing to more accurate and effective treatment plans.
In addition to its work with rating scales, the International Society for CNS Drug Development is also dedicated to conducting methodological research in CNS clinical trials. This research aims to improve the design and implementation of clinical trials for central nervous system disorders, ultimately leading to more reliable and impactful results. Furthermore, the society sponsors and conducts scientific meetings, providing a platform for researchers, healthcare professionals, and industry experts to share their findings, collaborate, and advance the field of CNS drug development.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The International Society For CNS Drug Development significantly advances research and development in the field of central nervous system disorders. By sponsoring and conducting scientific meetings, it fosters collaboration and knowledge exchange among researchers, clinicians, and industry professionals. Their commitment to methodological research in CNS clinical trials enhances the rigor and quality of studies, ultimately benefiting drug development processes.
One of their notable contributions is the development of the GRID HAM-D rating scale, which standardizes the assessment of depression severity, improving the consistency and accuracy of clinical evaluations. Additionally, the continued efforts on the DID rating scale demonstrate their focus on refining measurement tools for assessing dissociation in diverse populations.
Through these initiatives, the organization plays a crucial role in shaping the landscape of CNS drug development, ensuring that innovative therapies are grounded in robust scientific methodologies. Their impact is felt not only in advancing clinical research but also in enhancing patient care through improved assessment and treatment strategies in neuropsychiatric conditions.
This information is meant to be a general summary of International Society For Cns Drug Development. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2024.
- Investment Income: $15,324
- Program Service Revenue: $110,674
- Gross Receipts: $332,093
Assets and Liabilities:
- Total Assets: $732,271
- Total Liabilities: $3,002
- Net Assets: $729,269
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
GRID HAMD
Revenue
$11,000
HOTEL COMMISSION
Revenue
$2,831
MSQ SCALE FEES
Revenue
$21,000
REGISTRATION, MEETING FEE
Revenue
$75,843
Organization Details
Founding Year
2002
Principal Officer
Amir Kalali
Website
www.iscdd.orgNTEE Category
Code: U20 - Science research
If you are a representative of International Society For Cns Drug Development and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.